MAR-DAPSONE
MAR-DAPSONE
Approved
DIN Number
02481227
Drug Class
Human
Market Date
Nov 13, 2018
Company
HC
marcan pharmaceuticals inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02481227
AIG Number0106115001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J04BA02 DAPSONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:16.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
DAPSONEActive
Strength: 100 MG
Monograph: DAPSONE